TIL MEXC RealStocks
Own real TIL shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 06:07:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Instil Bio, Inc. (TIL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $5.42, with a market capitalization of $39.00M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.14 to $13.50. This page covers its latest market performance, valuation, price trends and company information.
$39.00M | |
$5.36 | |
$5.63 | |
$5.31 | |
$5.40 | |
117.72K | |
39.05K | |
-- | |
$13.50 | |
$5.14 | |
-- | |
2026-06-30 |
Instil Bio, Inc. (TIL) last closed at $5.42 as of 2026-11-18 20:59:32, up 0.56% ($0.03) from the previous close of $5.40.
During the latest regular trading session, TIL traded between $5.31 and $5.63, with a volume of 117.72K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Instil Bio, Inc. (TIL) moved from $6.47 to $5.42, representing a decline of 16.17% ($1.05).
The stock traded between $5.14 and $6.99 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 80.29 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 3.4%
TIL is currently trading at $5.42, placing it 3.4% of the way from its 52-week low of $5.14 to its 52-week high of $13.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 17 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Instil Bio, Inc. (TIL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to TIL, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between TIL shares and USD.
TIL Shares to USD
1.00 TIL shares = 5.424 USD
Calculations are estimates based on the latest available price and are for reference only.